Pellizzari Christine A
SEC-identified person · CIK 1127430 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Imunon, Inc. clsn | Director | filed 2021–2026 |
| Neurosense Therapeutics Ltd. NRSN | Director | filed 2026–2026 |
| Tempest Therapeutics, Inc. TPST | Director | filed 2021–2026 |
| Science 37 Holdings, Inc. SNCE | Chief Legal and HR Officer | filed 2021–2024 |
| Insmed Inc INSM | General Counsel & Secretary | filed 2013–2021 |
| Aegerion Pharmaceuticals, Inc. AEGR | EVP, Gen. Counsel & Secretary | filed 2010–2010 |
| Dendrite International INC DRTE | Sr VP, General Counsel & Secty | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.